Commonwealth Equity Services, LLC Adamis Pharmaceuticals Corp Transaction History

Commonwealth Equity Services, LLC

  • $66 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 05, 2020
SELL
$0.52 - $1.45 $9,100 - $25,375
-17,500 Closed
0 $0
Q4 2019

Feb 05, 2020
BUY
$0.51 - $1.26 $8,925 - $22,050
17,500 New
17,500 $12,000
Q3 2018

Nov 06, 2018
SELL
$2.25 - $4.8 $25,875 - $55,200
-11,500 Closed
0 $0
Q2 2018

Jul 31, 2018
BUY
$3.2 - $4.7 $36,800 - $54,050
11,500 New
11,500 $37,000

About Adamis Pharmaceuticals Corp

ADMP Quotes by TradingView
  • Ticker ADMP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 149,983,008
  • Market Cap $73.5M
  • Description
  • Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory disease in the United States. The company's product candidates comprise SYMJEPI epinephrine pre-filled syringe injectable products for use in the emerg...
More about ADMP
Track This Portfolio

Track Commonwealth Equity Services, LLC Portfolio

Follow Commonwealth Equity Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Commonwealth Equity Services, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email